Page last updated: 2024-08-23

daunorubicin and Fatty Liver, Nonalcoholic

daunorubicin has been researched along with Fatty Liver, Nonalcoholic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, H; Hori, T; Iesato, K; Igarashi, K; Kikuchi, N; Miyanishi, K; Saito, M; Tsutsumi, H; Yamamoto, M1

Other Studies

1 other study(ies) available for daunorubicin and Fatty Liver, Nonalcoholic

ArticleYear
Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia.
    International journal of hematology, 2018, Volume: 107, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; Child; Daunorubicin; gamma-Glutamyltransferase; Humans; Induction Chemotherapy; Male; Non-alcoholic Fatty Liver Disease; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Tomography, X-Ray Computed; Vincristine

2018